MREO · Mereo BioPharma Group plc

NasdaqHealthcareBiotechnology

Mereo Biopharma Group Plc Is A United Kingdom (U.K.) Based Biopharmaceutical Company Focused On The Development Of Therapeutics For Rare Diseases. The Company Has Developed A Portfolio Of Late-Stage Clinical Product Candidates, And Its Two Rare Disease Product Candidates Are Setrusumab For The Treatment Of Osteogenesis Imperfecta (Oi) And Alvelestat, Mainly For The Treatment Of Severe Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (Aatd-Ld).

HealthcareNasdaqGB

FLOAT

159.6M

FREE FLOAT %

100%

SHARES O/S

159.7M

MARKET CAP

$45.0M

EXCHANGE

Nasdaq

COUNTRY

MREO Catalyst History

No catalysts recorded for MREO yet

Day Trader Sniper hasn't classified a publishable catalyst for MREO yet. New events appear here as they're scored.

Be early on the next MREO spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

MREO · Mereo BioPharma Group plc

MREO Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.